trial · primary record
Tirzepatide
Longevity
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 22 |
| Primary completion | 2028-09 |
| Primary endpoint | Change in Proteomic Brain Age Gap From Baseline to Month 6 |
| Registry ID | NCT07906041 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:41:35.827Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07906041
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Tirzepatide · approval
- Tirzepatide · compound